Patents by Inventor Roger Crowther

Roger Crowther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stimulation of bone growth with thrombin peptide derivatives
    Publication number: 20050227923
    Abstract: Disclosed is a method of stimulating bone growth at a site in a subject in need of osteoinduction. The method comprises the step of administering a therapeutically effective amount of an agonist of the non-proteolytically activated thrombin receptor to the site.
    Type: Application
    Filed: January 18, 2005
    Publication date: October 13, 2005
    Applicant: The Board of Regents, The University of Texas System
    Inventors: Darrell Carney, Roger Crowther, David Simmons, Jinping Yang, William Redin
  • Pharmaceutical composition for thrombin peptide derivatives
    Publication number: 20050203017
    Abstract: Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.
    Type: Application
    Filed: December 30, 2004
    Publication date: September 15, 2005
    Applicant: The Board of Regents, The University of Texas System
    Inventors: David Hobson, Roger Crowther, Darrell Carney, Andrew Tang
  • Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
    Publication number: 20050181996
    Abstract: Disclosed is a method of stimulating cartilage growth, repair or regeneration at a site in a subject in need of such growth, repair or regeneration. The method comprises the step of administering a therapeutically effective amount of an agonist of the non-proteolytically activated thrombin receptor to the site. Also disclosed is a method of stimulating the proliferation and expansion of chrondrocytes in vitro. The method comprises culturing chrondrocytes in the presence of a stimulating amount of an NPAR agonist.
    Type: Application
    Filed: November 29, 2004
    Publication date: August 18, 2005
    Applicant: The Board of Regents, The University of Texas System
    Inventors: Darrell Carney, Roger Crowther, Janet Stiernberg, John Bergmann